Advanced search
1 file | 285.25 KB

Targeting inflammation using selective glucocorticoid receptor modulators

Karolien De Bosscher (UGent) , Guy Haegeman (UGent) and Dirk Elewaut (UGent)
Author
Organization
Abstract
Glucocorticoids have been used since several decades in a variety of diseases in view of their potent anti-inflammatory properties. Nevertheless, the widespread use of glucocorticoids is hampered by the risk of side effects. Because the effects of glucocorticoids are mediated at large through interaction with the glucocorticoid receptor, which results in anti-inflammatory effects as well as side effects, much attention has been given to understanding the molecular regulation. Over the past decade, remarkable progress has been made in the mechanisms mediating glucocorticoid receptor dependent gene regulation. In this review we provide an overview of recent progress in understanding the mode of action of glucocorticoids and novel strategies to dissociate anti-inflammatory from metabolic side effects.
Keywords
GENE REPRESSION, PLANT-ORIGIN, RHEUMATOID-ARTHRITIS, CORTICOSTEROID-BINDING GLOBULIN, AZIRIDINE PRECURSOR, IN-VIVO, MOLECULAR-MECHANISMS, DNA-BINDING, KAPPA-B, LIGAND

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 285.25 KB

Citation

Please use this url to cite or link to this publication:

Chicago
De Bosscher, Karolien, Guy Haegeman, and Dirk Elewaut. 2010. “Targeting Inflammation Using Selective Glucocorticoid Receptor Modulators.” Current Opinion in Pharmacology 10 (4): 497–504.
APA
De Bosscher, K., Haegeman, G., & Elewaut, D. (2010). Targeting inflammation using selective glucocorticoid receptor modulators. CURRENT OPINION IN PHARMACOLOGY, 10(4), 497–504.
Vancouver
1.
De Bosscher K, Haegeman G, Elewaut D. Targeting inflammation using selective glucocorticoid receptor modulators. CURRENT OPINION IN PHARMACOLOGY. 2010;10(4):497–504.
MLA
De Bosscher, Karolien, Guy Haegeman, and Dirk Elewaut. “Targeting Inflammation Using Selective Glucocorticoid Receptor Modulators.” CURRENT OPINION IN PHARMACOLOGY 10.4 (2010): 497–504. Print.
@article{1094948,
  abstract     = {Glucocorticoids have been used since several decades in a variety of diseases in view of their potent anti-inflammatory properties. Nevertheless, the widespread use of glucocorticoids is hampered by the risk of side effects. Because the effects of glucocorticoids are mediated at large through interaction with the glucocorticoid receptor, which results in anti-inflammatory effects as well as side effects, much attention has been given to understanding the molecular regulation. Over the past decade, remarkable progress has been made in the mechanisms mediating glucocorticoid receptor dependent gene regulation. In this review we provide an overview of recent progress in understanding the mode of action of glucocorticoids and novel strategies to dissociate anti-inflammatory from metabolic side effects.},
  author       = {De Bosscher, Karolien and Haegeman, Guy and Elewaut, Dirk},
  issn         = {1471-4892},
  journal      = {CURRENT OPINION IN PHARMACOLOGY},
  keyword      = {GENE REPRESSION,PLANT-ORIGIN,RHEUMATOID-ARTHRITIS,CORTICOSTEROID-BINDING GLOBULIN,AZIRIDINE PRECURSOR,IN-VIVO,MOLECULAR-MECHANISMS,DNA-BINDING,KAPPA-B,LIGAND},
  language     = {eng},
  number       = {4},
  pages        = {497--504},
  title        = {Targeting inflammation using selective glucocorticoid receptor modulators},
  url          = {http://dx.doi.org/10.1016/j.coph.2010.04.007},
  volume       = {10},
  year         = {2010},
}

Altmetric
View in Altmetric
Web of Science
Times cited: